Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LATANOPROST' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 129 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bron, AM; Denis, P; Nordmann, JP; Rouland, JF; Sellem, E; Johansson, M
      Additive IOP-reducing effect of latanoprost in patients insufficiently controlled on timolol

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    2. Larsson, LI
      The effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    3. Polo, V; Larrosa, JM; Gomez, ML; Pablo, L; Honrubia, FM
      Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    4. Linden, C
      Therapeutic potential of prostaglandin analogues in glaucoma

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    5. Cantor, LB
      Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    6. Bhattacherjee, P; Paterson, CA; Percicot, C
      Studies on receptor binding and signal transduction pathways of unoprostone isopropyl

      JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    7. Liu, JHK
      Diurnal measurement of intraocular pressure

      JOURNAL OF GLAUCOMA
    8. Morgan, PV; Proniuk, S; Blanchard, J; Noecker, RJ
      Effect of temperature and light on the stability of latanoprost and its clinical relevance

      JOURNAL OF GLAUCOMA
    9. Chiba, T; Kashiwagi, K; Kogure, S; Abe, K; Shibuya, T; Furuichi, M; Iijima, H; Tsukahara, S
      Iridial pigmentation induced by latanoprost ophthalmic solution in Japanese glaucoma patients

      JOURNAL OF GLAUCOMA
    10. Tsai, JC; Sivak-Callcott, JA; Haik, BG; Zhang, J; McLean, IW
      Latanoprost-induced iris heterochromia and open-angle glaucoma: A clinicopathologic report

      JOURNAL OF GLAUCOMA
    11. Goldberg, I; Cunha-Vaz, J; Jakobsen, JE; Nordmann, JP; Trost, E; Sullivan, EK
      Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension

      JOURNAL OF GLAUCOMA
    12. Petounis, A; Mylopoulos, N; Kandarakis, A; Andreanos, D; Dimitrakoulias, N
      Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: A randomized, open-label, multicenter study inGreece

      JOURNAL OF GLAUCOMA
    13. Serle, JB; Wang, RF; Mittag, TW; Shen, F; Podos, SM
      Effect of pilocarpine 4% in combination with latanoprost 0.005% or 8-iso prostaglandin E-2 0.1% on intraocular pressure in laser-induced glaucomatousmonkey eyes

      JOURNAL OF GLAUCOMA
    14. Lee, DA; Gornbein, JA
      Effectiveness and safety of brimonidine as adjunctive therapy for patientswith elevated intraocular pressure in a large, open-label community trial

      JOURNAL OF GLAUCOMA
    15. Furuichi, M; Chiba, T; Abe, K; Kogure, S; Iijima, H; Tsukahara, S; Kashiwagi, K
      Cystoid macular edema associated with topical latanoprost in glaucomatous eyes with a normally functioning blood-ocular barrier

      JOURNAL OF GLAUCOMA
    16. Larsson, LI
      Effect on intraocular pressure during 24 hours after repeated administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension

      JOURNAL OF GLAUCOMA
    17. Konstas, AGP; Lake, S; Maltezos, AC; Holmes, KT; Stewart, WC
      Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine third-line therapy in exfoliation glaucoma

      EYE
    18. Kuba, GB; Kurnatowski-Billion, M; Neuser, AM; Austermann, P
      Effect of Latanoprost on ocular hemodynamics and contrast sensitivity

      OPHTHALMOLOGE
    19. Herkel, U; Pfeiffer, N
      Innovative glaucoma therapy. Glaucoma therapy with topical carbonic anhydrase inhibitors

      OPHTHALMOLOGE
    20. Rainer, G; Menapace, R; Findl, O; Petternel, V; Kiss, B; Georgopoulos, M
      Effect of topical brimonidine on intraocular pressure after small incisioncataract surgery

      JOURNAL OF CATARACT AND REFRACTIVE SURGERY
    21. Gandolfi, S; Simmons, ST; Sturm, R; Chen, KK; Vandenburgh, AM
      Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension

      ADVANCES IN THERAPY
    22. Takamoto, T; Schwartz, B; Cantor, LB; Hoop, JS; Steffens, T
      Measurement of iris color using computerized image analysis

      CURRENT EYE RESEARCH
    23. Brandt, JD; VanDenburgh, AM; Chen, K; Whitcup, SM
      Comparison of once- or twice-daily bimatoprost with twice-daily timolol inpatients with elevated IOP - A 3-month clinical trial

      OPHTHALMOLOGY
    24. Yu, DY; Su, EN; Cringle, SJ; Schoch, C; Percicot, CP; Lambrou, GN
      Comparison of the vasoactive effects of the docosanoid unoprostone and selected prostanoids on isolated perfused retinal arterioles

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    25. Anthony, TL; Lindsey, JD; Aihara, M; Weinreb, RN
      Detection of prostaglandin EP1, EP2, and FP receptor subtypes in human sclera

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    26. Kamphuis, W; Schneemann, A; van Beek, LJ; Smit, AB; Hoyng, PFJ; Koya, E
      Prostanoid receptor gene expression profile in human trabecular meshwork: A quantitative real-time PCR approach

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    27. DuBiner, H; Cooke, D; Dirks, M; Stewart, WC; VanDenburgh, AM; Felix, C
      Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: A 30-day comparison with latanoprost

      SURVEY OF OPHTHALMOLOGY
    28. Sherwood, M; Brandt, J
      Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure

      SURVEY OF OPHTHALMOLOGY
    29. Loeffler, KU; Sahm, M; Spitznas, M
      Short-time application of latanoprost does not stimulate melanogenesis in bovine ocular melanin-containing cells in vitro

      OPHTHALMIC RESEARCH
    30. Waheed, NK; Miserocchi, E; Foster, CS
      Ocular concerns in juvenile rheumatoid arthritis

      INTERNATIONAL OPHTHALMOLOGY CLINICS
    31. Hu, DN; McCormick, SA; Woodward, DF
      A functional study on prostanoid receptors involved in cultured human iridal melanocyte stimulation

      EXPERIMENTAL EYE RESEARCH
    32. Drago, F; Valzelli, S; Emmi, I; Marino, A; Scalia, CC; Marino, V
      Latanoprost exerts neuroprotective activity in vitro and in vivo

      EXPERIMENTAL EYE RESEARCH
    33. Laibovitz, RA; VanDenburgh, AM; Felix, C; David, R; Batoosingh, A; Rosenthal, A; Cheetham, J
      Comparison of the ocular hypotensive lipid AGN 192024 with timolol - Dosing, efficacy and safety evaluation of a novel compound for glaucoma management

      ARCHIVES OF OPHTHALMOLOGY
    34. Miyake, K; Ota, I; Ibaraki, N; Akura, J; Ichihashi, S; Shibuya, Y; Maekubo, K; Miyake, S
      Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia

      ARCHIVES OF OPHTHALMOLOGY
    35. Hoffman, J
      No relationship between advertising and editorial acceptance

      ARCHIVES OF OPHTHALMOLOGY
    36. Orengo-Nania, S; Landry, T; Von Tress, M; Silver, LH; Weiner, A; Davis, AA
      Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%

      AMERICAN JOURNAL OF OPHTHALMOLOGY
    37. Stjernschantz, J; Ocklind, A; Wentzel, P; Lake, S; Hu, DN
      Latanoprost-induced increase of tyrosinase transcription in iridial melanocytes

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    38. Jin, NY; Stjernschantz, J
      Effects of prostaglandins on form deprivation myopia in the chick

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    39. Tsukamoto, H; Yokoyama, T; Okada, K; Okada, M; Mochizuki, H; Mishima, HK
      Substituting latanoprost (Xalatan (TM)) for isopropyl unoprostone (Rescula(TM)) in monotherapy and combination therapy

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    40. Thygesen, J; Aaen, K; Theodorsen, F; Kessing, SV; Prause, JU
      Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary open-angle glaucoma and ocular hypertension

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    41. Alm, A; Widengard, I
      Latanoprost: Experience of 2-year treatment in Scandinavia

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    42. Troiano, P; Oldani, A; Gozzini, C; Iraci, M; Dalpozzo, R; Baratta, M; De Mattia, M
      Latanoprost 0.005%: evaluation of its effect on accommodative capacity

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    43. Giraldi, JP; Mollicone, A; Seguto, D; Simeone, L; Zaccara, F
      Latanoprost and the ibopamine test: a year's experience

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    44. Abramovitz, M; Adam, M; Boie, Y; Carriere, MC; Denis, D; Godbout, C; Lamontagne, S; Rochette, C; Sawyer, N; Tremblay, NM; Belley, M; Gallant, M; Dufresne, C; Gareau, Y; Ruel, R; Juteau, H; Labelle, M; Ouimet, N; Metters, KM
      The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
    45. Stjernschantz, J; Selen, G; Astin, M; Resul, B
      Microvascular effects of selective prostaglandin analogues in the eye withspecial reference to latanoprost and glaucoma treatment

      PROGRESS IN RETINAL AND EYE RESEARCH
    46. Sanchez, JG
      Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension - A three-month randomised study

      EUROPEAN JOURNAL OF OPHTHALMOLOGY
    47. Vetrugno, M; Maino, A; Quaranta, GM; Cardia, L
      A randomized, comparative open-label study on the efficacy of latanoprost and timolol in steroid induced ocular hypertension after photorefractive keratectomy

      EUROPEAN JOURNAL OF OPHTHALMOLOGY
    48. Hedman, K; Alm, A
      A pooled-data analysis of three randomized, double-masked, six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timolol

      EUROPEAN JOURNAL OF OPHTHALMOLOGY
    49. Lenart, TD; Drack, AV; Tarnuzzer, RW; Fernandes, A; Lambert, SR
      Heterochromia after pediatric cataract surgery

      JOURNAL OF AAPOS
    50. Lee, DA; Gornbein, J; Abrams, C
      The effectiveness and safety of brimonidine as mono-, combination, or replacement therapy for patients with primary open-angle glaucoma or ocular hypertension: A post hoc analysis of an open-label community trial

      JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    51. Wang, RF; Serle, JB; Gagliuso, DJ; Podos, SM
      Comparison of the ocular hypotensive effect of brimonidine, dorzolamide, latanoprost, or artificial tears added to timolol in glaucomatous monkey eyes

      JOURNAL OF GLAUCOMA
    52. Lima, MC; Paranhos, A; Salim, S; Honkanen, R; Devgan, L; Wand, M; Gaudio, AR; Shields, MB
      Visually significant cystoid macular edema in pseudophakic and aphakic patients with glaucoma receiving latanoprost

      JOURNAL OF GLAUCOMA
    53. Scherer, WJ; Hauber, FA
      Effect of latanoprost on intraocular pressure in steroid-induced glaucoma

      JOURNAL OF GLAUCOMA
    54. Susanna, R; Nicolela, MT; Oga, E
      Additive effect of latanoprost to the combination of timolol and dorzolamide

      JOURNAL OF GLAUCOMA
    55. Camras, CB; Neely, DG; Weiss, EL
      Latanoprost-induced iris color darkening: A case report with long-term follow-up

      JOURNAL OF GLAUCOMA
    56. Alm, A
      Uveoscleral outflow

      EYE
    57. Migdal, C
      Glaucoma medical treatment: philosophy, principles and practice

      EYE
    58. El-Shabrawi, Y; Eckhardt, M; Berghold, A; Faulborn, J; Auboeck, L; Mangge, H; Ardjomand, N
      Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone

      EYE
    59. Dinslage, S; Diestelhorst, M; Kuhner, H; Krieglstein, GK
      The influence of Latanoprost 0.005% on the pupil reaction in human eyes

      OPHTHALMOLOGE
    60. Melgosa, M; Rivas, MJ; Gomez, L; Hita, E
      Towards a colorimetric characterization of the human iris

      OPHTHALMIC AND PHYSIOLOGICAL OPTICS
    61. Simmons, ST; Samuelson, TW
      Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma

      CLINICAL THERAPEUTICS
    62. Einarson, TR; Kulin, NA; Tingey, D; Iskedjian, M
      Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma

      CLINICAL THERAPEUTICS
    63. Ishii, K; Araie, M
      Effect of topical latanoprost-timolol combined therapy on retinal blood flow and circulation of optic nerve head tissue in cynomolgus monkeys

      JAPANESE JOURNAL OF OPHTHALMOLOGY
    64. Suzuki, M; Mishima, HK; Masuda, K; Araie, M; Kitazawa, Y; Azuma, I
      Efficacy and safety of latanoprost eye drops for glaucoma treatment: A 1-year study in Japan

      JAPANESE JOURNAL OF OPHTHALMOLOGY
    65. Dodds, EM
      Treatment strategies in patients with anterior uveitis

      INTERNATIONAL OPHTHALMOLOGY CLINICS
    66. Dutkiewicz, R; Albert, DM; Levin, LA
      Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines

      EXPERIMENTAL EYE RESEARCH
    67. Hu, DN; Stjernschantz, J; McCormick, SA
      Effect of prostaglandins A(2), E-1, F-2 alpha and latanoprost on cultured human iridal melanocytes

      EXPERIMENTAL EYE RESEARCH
    68. Gaynor, BD; Stamper, RL; Cunningham, ET
      Presumed activation of herpetic keratouveitis after argon laser peripheraliridotomy

      AMERICAN JOURNAL OF OPHTHALMOLOGY
    69. Smith, SL; Pruitt, CA; Sine, CS; Hudgins, AC; Stewart, WC
      Latanoprost 0.005% and anterior segment uveitis

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    70. Linden, C
      Aspects on prostanoid and cholinergic effects on aqueous humour dynamics in human eyes

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    71. Martin, L
      Clinical experience with Latanoprost: a retrospective study of 153 patients

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    72. Smith, SL; Pruitt, CA; Sine, CS; Hudgins, AC; Stewart, WC
      The use of latanoprost 0.005% once daily to simplify medical therapy in patients with primary open-angle glaucoma or ocular hypertension

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    73. Troiano, P; Oldani, A; Iraci, M; Gozzini, C; Baratta, M; Ratiglia, R
      Long-term latanoprost efficacy and tolerability in primary open-angle glaucoma

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    74. Camras, CB; Toris, CB; Tamesis, RR
      Efficacy and adverse effects of medications used in the treatment of glaucoma.

      DRUGS & AGING
    75. Stewart, WC; Hudgins, AC; Pruitt, CA; Sine, C
      Daily cost of newer glaucoma agents

      JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    76. Le, HH; Chang, MR; Cheng, Q; Lee, DA; Hartenbaum, D
      The effectiveness and safety of dorzolamide 2% in addition to multiple topical antiglaucoma medications

      JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    77. Kent, AR; Vroman, DT; Thomas, TJ; Hebert, RL; Crosson, CE
      Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension

      JOURNAL OF GLAUCOMA
    78. Altuna, JC; Greenfield, DS; Wand, M; Liebmann, JM; Taglia, DP; Kaufman, PL; Cioffi, GA; Lee, DA; Robin, AL; Crichton, A; Costa, VP; Ritch, R
      Latanoprost in glaucoma associated with Sturge-Weber syndrome: Benefits and side-effects

      JOURNAL OF GLAUCOMA
    79. Bucci, MG
      Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: A randomized, observer-masked multicenter study in patients with open-angle glaucoma

      JOURNAL OF GLAUCOMA
    80. McKibbin, M; Menage, MJ
      The effect of once-daily latanoprost on intraocular pressure and pulsatileocular blood flow in normal tension glaucoma

      EYE
    81. Kobelt, G; Jonsson, L
      Modeling cost of treatment with new topical treatments for glaucoma - Results from France and the United Kingdom

      INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
    82. Schwartzenberg, GWST; Buys, YM
      Efficacy of brimonidine 0.2% as adjunctive therapy for patients with glaucoma inadequately controlled with otherwise maximal medical therapy

      OPHTHALMOLOGY
    83. Dijkstra, BG; Schneemann, A; Hoyng, PF
      Flow after prostaglandin E-1 is mediated by receptor-coupled adenylyl cyclase in human anterior segments

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    84. Veyrac, G; Chiffoleau, A; Cellerin, L; Larousse, C; Bourin, M
      Latanprost (XALATAN (R)) and systemic respiratory side effect? A case report

      THERAPIE
    85. Seong, GJ; Lee, HK; Hong, YJ
      Effects of 0.005% latanoprost on optic nerve head and peripapillary retinal blood flow

      OPHTHALMOLOGICA
    86. Lindquist, NG; Larsson, BS; Stjernschantz, J
      Increased pigmentation of iridial melanocytes in primates induced by a prostaglandin analogue

      EXPERIMENTAL EYE RESEARCH
    87. Drago, F; Marino, A; La Manna, C
      alpha-methyl-p-tyrosine inhibits latanoprost-induced melanogenesis in vitro

      EXPERIMENTAL EYE RESEARCH
    88. Sjoquist, B; Tajallaei, S; Stjernschantz, J
      Pharmacokinetics of latanoprost in the cynomolgus monkey - 1st Communication: Single intravenous, oral or topical administration on the eye

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    89. Sjoquist, B; Uhlin, A; Byding, P; Stjernschantz, J
      Pharmacokinetics of latanoprost in the cynomolgus monkey - 2nd Communication: Repeated topical administration on the eye

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    90. Sjoquist, B; Johansson, A; Stjernschantz, J
      Pharmacokinetics of latanoprost in the cynomolgus monkey - 3rd Communication: Tissue distribution after topical administration on the eye studied by whole body autoradiography

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    91. Sagara, T; Gaton, DD; Lindsey, JD; Gabelt, BT; Kaufman, PL; Weinreb, RN
      Topical prostaglandin F-2 alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway

      ARCHIVES OF OPHTHALMOLOGY
    92. Fiscella, RG; Geller, JL; Gryz, LL; Wilensky, J; Viana, M
      Cost considerations of medical therapy for glaucoma

      AMERICAN JOURNAL OF OPHTHALMOLOGY
    93. Lo Presti, L; Morgese, A; Ravot, M; Brogliatti, B; Carenini, BB
      Ultrabiomicroscopic study of the effects of brimonidine, apraclonidine, latanoprost and ibopamine on the chamber angle and ciliary body

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    94. Montrone, F; Macinagrossa, G; Tenerelli, F
      Sympathetic use of latanoprost 0.005% in 30 eyes

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    95. Vetrugno, M; Cantatore, F; Gigante, G; Cardia, L
      Latanoprost 0.005% in POAG: effects on IOP and ocular blood flow

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    96. FISCELLA RG
      COSTS OF GLAUCOMA MEDICATIONS

      American journal of health-system pharmacy
    97. SCHMIDTBORN F
      SYSTEMIC SIDE-EFFECTS OF LATANOPROST THERAPY IN A CHILD WITH ANIRIDIAAND GLAUCOMA

      Der Ophthalmologe
    98. KOBELT G; JONSSON L; GERDTHAM U; KRIEGLSTEIN GK
      DIRECT COSTS OF GLAUCOMA MANAGEMENT FOLLOWING INITIATION OF MEDICAL THERAPY - A SIMULATION-MODEL BASED ON AN OBSERVATIONAL STUDY OF GLAUCOMA TREATMENT IN GERMANY

      Graefe's archive for clinical and experimental ophthalmology
    99. BERG A; EKWALL AKH; RUBIN K; STJERNSCHANTZ J; REED RK
      EFFECT OF PGE(1), PGI(2), AND PGF(2-ALPHA) ANALOGS ON COLLAGEN GEL COMPACTION IN-VITRO AND INTERSTITIAL PRESSURE IN-VIVO

      American journal of physiology. Heart and circulatory physiology
    100. MULVIHILL A
      MEDICAL-MANAGEMENT OF GLAUCOMA

      Irish medical journal


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 06:33:15